Outlook Therapeutics, Inc. (OTLK): Going concern doubt
Severity scores the disclosed filing signal, not a judgment about the company or its securities.
What was disclosed
See Note 7 – Debt, for more information related to the March 2025 Note. As a result, there is substantial doubt about the Company’s ability to continue as a going concern.
Why it matters
A going-concern disclosure reflects substantial doubt about the company's ability to continue operating.